Verily

Excited to be presenting at the Regeneron Digital Biomarker Summit on May 13th! I'll be speaking on "Digital Endpoints for Parkinson’s Disease Trials," highlighting the role of active and passive measures in validating treatment efficacy and the applications of Verily’s Numetric Watch. You can learn more about the event here: https://lnkd.in/gS3sy6V2 Hope to see you there! #RegeneronDigitalBiomarkers

Managing clinical trials comes with challenges—disjointed workflows, outdated software, and manual execution against static PDF protocols. There’s a better way to protocol. ICYM our webinar, it's now available on demand. Hear Verily experts Lauren Sutton and Yugang Jia, Ph.D MPH share how Verily Viewpoint Digital Protocols can: ✅ Reduce the time and effort needed to manage trials ✅ Bring drugs to market faster ✅ Drive connections and efficiencies at research sites Plus, get a sneak peek at Verily’s roadmap! Watch now: https://veri.ly/3EOWTsd #ClinicalTrials #CTMS

I’m thrilled to welcome new organizations who will use Verily Workbench to manage large biomedical datasets. Powered by the Verily platform, Workbench is a scalable research environment used to unify multimodal data and accelerate biomedical research. Plus, we’ve recently added new features that make it easier to govern, access, and analyze these data. Very pleased to be working with NashBio, University of Oxford, National Institutes of Health Intramural Center for Alzheimer’s and Related Dementias (CARD), and Foundation for the National Institutes of Health AMP PDRD! Learn more: https://veri.ly/4jeKE7p #BiomedicalData #ClinicalResearch #PrecisionHealth

🎉 Congratulations to our CEO Stephen Gillett for being named to Dallas Innovates' 2025 AI 75 List, an award that recognizes leaders, visionaries, creators, and influencers fueling the growth of artificial intelligence in Dallas-Fort Worth. "We are using large-scale datasets on the Verily platform to advance AI applications and create new methods to make AI fit for purpose for healthcare," said Stephen. Check out the full list of AI innovators: https://veri.ly/4iFmYb2 #AIInHealthcare #PrecisionHealth

I am excited to share that Verily has been awarded a significant grant from The Michael J. Fox Foundation for Parkinson's Research. This grant will build on our previous research efforts, enabling us to generate one of the most extensive molecular data assets of its kind. Global researchers will access the data we generate through Verily’s platform. This resource will fuel research into genetics, immunology, and metabolism, with the ultimate goal of improving the lives of those with Parkinson's and their caregivers.  You can read more here: https://veri.ly/3GsGwlt https://lnkd.in/g9jgakKm

Organizations are managing more multi-modal healthcare data than ever before, but are often faced with data silos that prevent them from maximizing its value. A new whitepaper from Verily, "Transforming healthcare with data," details how Verily Workbench can help research teams securely share, collaborate and drive meaningful insights. Download it here: https://veri.ly/4iuShFe #lifesciences #research

We are proud to announce a $14.7M grant from The Michael J. Fox Foundation for Parkinson's Research (MJFF) to generate one of the world's largest, high-dimensional molecular datasets of Parkinson's patients. This data will be publicly available through Verily Workbench, empowering researchers globally to accelerate the development of new treatments and cures. “Scientific understanding of Parkinson’s disease has advanced significantly over the past decade, and we continue to seek new answers on its genetic, immunological, and molecular determinants,” said Mark Frasier, PhD, Chief Scientist at MJFF. Learn more: https://veri.ly/3GsGwlt #ParkinsonsDisease #ParkinsonsAwareness #HealthData #PrecisionHealth

Last chance to register! Join us tomorrow, April 30th, for a webinar with Verily experts Sarah Thompson and David Burdick, Heidi Guetzkow from Aon, and moderator Lydia Ramsey Pflanzer from Endpoints News, to learn about Verily's personalized, AI-powered approach to personalized weight loss and diabetes management while navigating the complexities and costs of GLP-1s. Verily Lightpath is designed to ensure the right patients receive the right support with GLP-1s to help improve outcomes and drive lasting behavior change. Hope you can join! Register here: https://veri.ly/4hUGrUD #GLP1s #DiabetesManagement #VirtualCare #AI

Dr. Sarah Thompson is helping pave the way for more individuals with chronic conditions to have access to the right care and support through her work as a Verily clinical expert, healthcare innovator and leader. Read about Sarah's personal story and the experiences that shaped her passion to build effective, safe care programs enabled by Verily technology: https://veri.ly/44gsVrw You can also hear Sarah during our live webinar tomorrow, April 30. Register to learn how Verily’s personalized, AI-powered approach to care and management will unlock GLP-1 potential for better health. https://veri.ly/4hUGrUD #DiabetesManagement #VirtualCare #GLP1s

Hundreds of pages of protocols, 20+ systems… clinical trials are complex. But what if they didn't have to be? Stay tuned for a new #VerilyNof1 episode about how Verily is using AI to translate PDF protocols into digital models, partnering with the American Oncology Network to reimagine clinical research. 📷 Behind the scenes with Taylor Stutzman, Research Manager In the meantime, catch up on the docuseries, stories of our customers and partners harnessing diverse forms of health data and turning them into insights that transform lives: ✳️ A Watershed Moment https://lnkd.in/dMfQ9mWY ✳️ Eye on the Future https://lnkd.in/duPxpfY8 #HealthTech #AIinHealthcare #ClinicalResearch #ClinicalTrials